搜索结果：Genomics & informatics

Low-cost, high-throughput DNA and RNA sequencing (HTS) data is the backbone of the life sciences. Genome sequencing is now becoming a part of Predictive, Preventive, Personalized, and Participatory (termed 'P4') medicine. All genomic data are currently processed in energy-hungry computer clusters and centers, necessitating data transfer, consuming substantial energy, and wasting valuable time. Therefore, there is a need for fast, energy-efficient, and cost-efficient technologies that enable genomics research without requiring data centers and cloud platforms. We recently launched the BioPIM Project to leverage emerging processing-in-memory (PIM) technologies to enable energy- and cost-efficient analysis of bioinformatics workloads. The BioPIM Project focuses on co-designing algorithms and data structures commonly used in genomics with several PIM architectures to achieve the highest cost, energy, and time savings.

In biomedical research, validation of a new scientific discovery is tied to the reproducibility of its experimental results. However, in genomics, the definition and implementation of reproducibility still remain imprecise. Here, we argue that genomic reproducibility, defined as the ability of bioinformatics tools to maintain consistent genomics results across technical replicates, is key to generating scientific knowledge and enabling medical applications. We first discuss different concepts of reproducibility and then focus on reproducibility in the context of genomics, aiming to establish clear definitions of relevant terms. We then focus on the role of bioinformatics tools and their impact on genomic reproducibility and assess methods of evaluating bioinformatics tools in terms of genomic reproducibility. Lastly, we suggest best practices for enhancing genomic reproducibility, with an emphasis on assessing the performance of bioinformatics tools through rigorous testing across multiple technical replicates.

Rare diseases are collectively common, affecting approximately one in twenty individuals worldwide. In recent years, rapid progress has been made in rare disease diagnostics due to advances in DNA sequencing, development of new computational and experimental approaches to prioritize genes and genetic variants, and increased global exchange of clinical and genetic data. However, more than half of individuals suspected to have a rare disease lack a genetic diagnosis. The Genomics Research to Elucidate the Genetics of Rare Diseases (GREGoR) Consortium was initiated to study thousands of challenging rare disease cases and families and apply, standardize, and evaluate emerging genomics technologies and analytics to accelerate their adoption in clinical practice. Further, all data generated, currently representing ~7500 individuals from ~3000 families, is rapidly made available to researchers worldwide via the Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL) to catalyze global efforts to develop approaches for genetic diagnoses in rare diseases (https://gregorconsortium.org/data). The majority of these families have undergone prior clinical genetic testing

Rapid and reliable qualification of advanced materials remains a bottleneck in industrial manufacturing, particularly for heterogeneous structures produced via non-conventional additive manufacturing processes. This study introduces a novel framework that links microstructure informatics with a range of expert characterization knowledge using customized and hybrid vision-language representations (VLRs). By integrating deep semantic segmentation with pre-trained multi-modal models (CLIP and FLAVA), we encode both visual microstructural data and textual expert assessments into shared representations. To overcome limitations in general-purpose embeddings, we develop a customized similarity-based representation that incorporates both positive and negative references from expert-annotated images and their associated textual descriptions. This allows zero-shot classification of previously unseen microstructures through a net similarity scoring approach. Validation on an additively manufactured metal matrix composite dataset demonstrates the framework's ability to distinguish between acceptable and defective samples across a range of characterization criteria. Comparative analysis reveals

Long-range dependencies are critical for understanding genomic structure and function, yet most conventional methods struggle with them. Widely adopted transformer-based models, while excelling at short-context tasks, are limited by the attention module's quadratic computational complexity and inability to extrapolate to sequences longer than those seen in training. In this work, we explore State Space Models (SSMs) as a promising alternative by benchmarking two SSM-inspired architectures, Caduceus and Hawk, on long-range genomics modeling tasks under conditions parallel to a 50M parameter transformer baseline. We discover that SSMs match transformer performance and exhibit impressive zero-shot extrapolation across multiple tasks, handling contexts 10 to 100 times longer than those seen during training, indicating more generalizable representations better suited for modeling the long and complex human genome. Moreover, we demonstrate that these models can efficiently process sequences of 1M tokens on a single GPU, allowing for modeling entire genomic regions at once, even in labs with limited compute. Our findings establish SSMs as efficient and scalable for long-context genomic an

The effective visualization of genomic data is crucial for exploring and interpreting complex relationships within and across genes and genomes. Despite advances in developing dedicated bioinformatics software, common visualization tools often fail to efficiently integrate the diverse datasets produced in comparative genomics, lack intuitive interfaces to construct complex plots and are missing functionalities to inspect the underlying data iteratively and at scale. Here, we introduce gggenomes, a versatile R package designed to overcome these challenges by extending the widely used ggplot2 framework for comparative genomics. gggenomes is available from CRAN and GitHub, accompanied by detailed and user-friendly documentation (https://thackl.github.io/gggenomes).

In recent years, Reinforcement Learning (RL) has emerged as a powerful tool for solving a wide range of problems, including decision-making and genomics. The exponential growth of raw genomic data over the past two decades has exceeded the capacity of manual analysis, leading to a growing interest in automatic data analysis and processing. RL algorithms are capable of learning from experience with minimal human supervision, making them well-suited for genomic data analysis and interpretation. One of the key benefits of using RL is the reduced cost associated with collecting labeled training data, which is required for supervised learning. While there have been numerous studies examining the applications of Machine Learning (ML) in genomics, this survey focuses exclusively on the use of RL in various genomics research fields, including gene regulatory networks (GRNs), genome assembly, and sequence alignment. We present a comprehensive technical overview of existing studies on the application of RL in genomics, highlighting the strengths and limitations of these approaches. We then discuss potential research directions that are worthy of future exploration, including the development

Large AI models, or foundation models, are models recently emerging with massive scales both parameter-wise and data-wise, the magnitudes of which can reach beyond billions. Once pretrained, large AI models demonstrate impressive performance in various downstream tasks. A prime example is ChatGPT, whose capability has compelled people's imagination about the far-reaching influence that large AI models can have and their potential to transform different domains of our lives. In health informatics, the advent of large AI models has brought new paradigms for the design of methodologies. The scale of multi-modal data in the biomedical and health domain has been ever-expanding especially since the community embraced the era of deep learning, which provides the ground to develop, validate, and advance large AI models for breakthroughs in health-related areas. This article presents a comprehensive review of large AI models, from background to their applications. We identify seven key sectors in which large AI models are applicable and might have substantial influence, including 1) bioinformatics; 2) medical diagnosis; 3) medical imaging; 4) medical informatics; 5) medical education; 6) pu

Genome data are crucial in modern medicine, offering significant potential for diagnosis and treatment. Thanks to technological advancements, many millions of healthy and diseased genomes have already been sequenced; however, obtaining the most suitable data for a specific study, and specifically for validation studies, remains challenging with respect to scale and access. Therefore, in silico genomics sequence generators have been proposed as a possible solution. However, the current generators produce inferior data using mostly shallow (stochastic) connections, detected with limited computational complexity in the training data. This means they do not take the appropriate biological relations and constraints, that originally caused the observed connections, into consideration. To address this issue, we propose cancer-inspired genomics mapper model (CGMM), that combines genetic algorithm (GA) and deep learning (DL) methods to tackle this challenge. CGMM mimics processes that generate genetic variations and mutations to transform readily available control genomes into genomes with the desired phenotypes. We demonstrate that CGMM can generate synthetic genomes of selected phenotypes

The COVID-19 crisis has demonstrated the potential of cutting-edge genomics research. However, privacy of these sensitive pieces of information is an area of significant concern for genomics researchers. The current security models makes it difficult to create flexible and automated data sharing frameworks. These models also increases the complexity of adding or revoking access without contacting the data publisher. In this work, we investigate an automated attribute-based access control (AABAC) model for genomics data over Named Data Networking (NDN). AABAC secures the data itself rather than the storage location or transmission channel, provides automated data invalidation, and automates key retrieval and data validation while maintaining the ability to control access. We show that AABC when combined with NDN provide a secure and flexible combination for work with genomics research.

This paper will argue that one of the biggest challenges for livestock genomics is to make whole-genome sequencing and functional genomics applicable to breeding practice. It discusses potential explanations for why it is so difficult to consistently improve the accuracy of genomic prediction by means of whole-genome sequence data, and three potential attacks on the problem.

Large Genomic Foundation Models have recently achieved remarkable results and in-vivo translation capabilities. However these models quickly grow to over a few Billion of parameters and are expensive to run when compute is limited. To overcome this challenge, we present a distillation framework for transferring mRNA representations from a state of the art genomic foundation model into a much smaller model specialized for mRNA sequences, reducing the size by 200-fold. Embedding-level distillation worked better than logit based methods, which we found unstable. Benchmarking on mRNA-bench demonstrates that the distilled model achieves state-of-the-art performance among models of comparable size and competes with larger architectures for mRNA-related tasks. Our results highlight embedding-based distillation of mRNA sequences as an effective training strategy for biological foundation models. This enables similar efficient and scalable sequence modelling in genomics, particularly when large models are computationally challenging or infeasible.

Healthcare has witnessed an increased digitalization in the post-COVID world. Technologies such as the medical internet of things and wearable devices are generating a plethora of data available on the cloud anytime from anywhere. This data can be analyzed using advanced artificial intelligence techniques for diagnosis, prognosis, or even treatment of disease. This advancement comes with a major risk to protecting and securing protected health information (PHI). The prevailing regulations for preserving PHI are neither comprehensive nor easy to implement. The study first identifies twenty activities crucial for privacy and security, then categorizes them into five homogeneous categories namely: $\complement_1$ (Policy and Compliance Management), $\complement_2$ (Employee Training and Awareness), $\complement_3$ (Data Protection and Privacy Control), $\complement_4$ (Monitoring and Response), and $\complement_5$ (Technology and Infrastructure Security) and prioritizes these categories to provide a framework for the implementation of privacy and security in a wise manner. The framework utilized the Delphi Method to identify activities, criteria for categorization, and prioritization.

Pathway Tools is a bioinformatics software environment with a broad set of capabilities. The software provides genome-informatics tools such as a genome browser, sequence alignments, a genome-variant analyzer, and comparative-genomics operations. It offers metabolic-informatics tools, such as metabolic reconstruction, quantitative metabolic modeling, prediction of reaction atom mappings, and metabolic route search. Pathway Tools also provides regulatory-informatics tools, such as the ability to represent and visualize a wide range of regulatory interactions. The software creates and manages a type of organism-specific database called a Pathway/Genome Database (PGDB), which the software enables database curators to interactively edit. It supports web publishing of PGDBs and provides a large number of query, visualization, and omics-data analysis tools. Scientists around the world have created more than 45,000 PGDBs by using Pathway Tools, many of which are curated databases for important model organisms. Those PGDBs can be exchanged using a peer-to-peer database-sharing system called the PGDB Registry.

The emergence of telomere-to-telomere (T2T) genome assemblies has opened new avenues for comparative genomics, yet effective tokenization strategies for genomic sequences remain underexplored. In this pilot study, we apply Byte Pair Encoding (BPE) to nine T2T primate genomes including three human assemblies by training independent BPE tokenizers with a fixed vocabulary of 512,000 tokens using our custom tool, dnaBPE. Our analysis reveals that only 11,569 tokens are shared across all assemblies, while nearly 991,854 tokens are unique to a single genome, indicating a rapid decline in shared vocabulary with increasing assembly comparisons. Moreover, phylogenetic trees derived from token overlap failed to recapitulate established primate relationships, a discrepancy attributed to the disproportionate influence of species-specific high-copy repetitive elements. These findings underscore the dual nature of BPE tokenization: while it effectively compresses repetitive sequences, its sensitivity to high-copy elements limits its utility as a universal tool for comparative genomics. We discuss potential hybrid strategies and repeat-masking approaches to refine genomic tokenization, emphasizin

Searching for similar genomic sequences is an essential and fundamental step in biomedical research and an overwhelming majority of genomic analyses. State-of-the-art computational methods performing such comparisons fail to cope with the exponential growth of genomic sequencing data. We introduce the concept of sparsified genomics where we systematically exclude a large number of bases from genomic sequences and enable much faster and more memory-efficient processing of the sparsified, shorter genomic sequences, while providing similar or even higher accuracy compared to processing non-sparsified sequences. Sparsified genomics provides significant benefits to many genomic analyses and has broad applicability. We show that sparsifying genomic sequences greatly accelerates the state-of-the-art read mapper (minimap2) by 2.57-5.38x, 1.13-2.78x, and 3.52-6.28x using real Illumina, HiFi, and ONT reads, respectively, while providing up to 2.1x smaller memory footprint, 2x smaller index size, and more truly detected small and structural variations compared to minimap2. Sparsifying genomic sequences makes containment search through very large genomes and large databases 72.7-75.88x faster

Genomic language models (gLMs) have transformed computational biology, achieving state-of-the-art performance across genomic tasks. Yet a fundamental question threatens the foundation of this success: do these models learn the mechanistic principles governing gene regulation, or do they merely exploit statistical shortcuts? We introduce the Mechanistic Invariance Test (MIT), a rigorous 650-sequence benchmark across 8 classes with scrambled controls that enables clean discrimination between compositional sensitivity and genuine positional understanding. We evaluate five gLMs spanning all major architectural paradigms (autoregressive, masked, and bidirectional state-space models) and uncover a universal failure mode. Through systematic mechanistic probing via AT titration, positional ablation, spacing perturbation, and strand orientation tests, we demonstrate that apparent compensation sensitivity is driven entirely by AT content correlation (r=0.78-0.96 across architectures), not positional regulatory logic. The failures are striking: Evo2-1B and Caduceus score regulatory elements at incorrect positions higher than correct positions, inverting biological reality. All models are stra

The Global Alliance for Genomics and Health (GA4GH) Beacon protocol lets researchers ask whether a genomic variant has been observed in a participating cohort and receive aggregate variant-level counts. As Beacon networks grow, two privacy risks remain: host institutions can see plaintext queries, and repeated rare-variant queries can support membership-inference attacks. We present bioETH-Beacon, a smart-contract prototype that runs the Beacon "aggregate count" query over encrypted data on a fully homomorphic Ethereum Virtual Machine (fhEVM). Hospitals upload encrypted marker-count entries, authorized researchers submit encrypted marker queries, and the contract returns an encrypted answer that is released, via an off-chain key-management service, only to the requester named in the contract's on-chain ACL. The design is organized as a 3x4 tier-by-query-family grid spanning genotype, sex, age, and phenotype queries, with tiers that trade stronger confidentiality for lower query cost. For genotype paths, the prototype can add bounded on-chain noise to mitigate probing attacks. Experiments on synthetic panels derived from a Polygenic Score (PGS) catalog show the expected scaling beha

Advancements in genomic research such as high-throughput sequencing techniques have driven modern genomic studies into "big data" disciplines. This data explosion is constantly challenging conventional methods used in genomics. In parallel with the urgent demand for robust algorithms, deep learning has succeeded in a variety of fields such as vision, speech, and text processing. Yet genomics entails unique challenges to deep learning since we are expecting from deep learning a superhuman intelligence that explores beyond our knowledge to interpret the genome. A powerful deep learning model should rely on insightful utilization of task-specific knowledge. In this paper, we briefly discuss the strengths of different deep learning models from a genomic perspective so as to fit each particular task with a proper deep architecture, and remark on practical considerations of developing modern deep learning architectures for genomics. We also provide a concise review of deep learning applications in various aspects of genomic research, as well as pointing out potential opportunities and obstacles for future genomics applications.